BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 9925290)

  • 1. Synthesis of a tetracyclic, conformationally constrained analogue of delta8-THC.
    Huffman JW; Yu S
    Bioorg Med Chem; 1998 Dec; 6(12):2281-8. PubMed ID: 9925290
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Synthesis and pharmacology of the isomeric methylheptyl-delta8-tetrahydrocannabinols.
    Huffman JW; Liddle J; Duncan SG; Yu S; Martin BR; Wiley JL
    Bioorg Med Chem; 1998 Dec; 6(12):2383-96. PubMed ID: 9925296
    [TBL] [Abstract][Full Text] [Related]  

  • 3. 3-(1',1'-Dimethylbutyl)-1-deoxy-delta8-THC and related compounds: synthesis of selective ligands for the CB2 receptor.
    Huffman JW; Liddle J; Yu S; Aung MM; Abood ME; Wiley JL; Martin BR
    Bioorg Med Chem; 1999 Dec; 7(12):2905-14. PubMed ID: 10658595
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Novel conformationally restricted tetracyclic analogs of delta8-tetrahydrocannabinol.
    Khanolkar AD; Lu D; Fan P; Tian X; Makriyannis A
    Bioorg Med Chem Lett; 1999 Aug; 9(15):2119-24. PubMed ID: 10465529
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Synthesis and pharmacology of a hybrid cannabinoid.
    Huffman JW; Lu J; Dai D; Kitaygorodskiy A; Wiley JL; Martin BR
    Bioorg Med Chem; 2000 Feb; 8(2):439-47. PubMed ID: 10722167
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Bornyl- and isobornyl-Delta8-tetrahydrocannabinols: a novel class of cannabinergic ligands.
    Lu D; Guo J; Duclos RI; Bowman AL; Makriyannis A
    J Med Chem; 2008 Oct; 51(20):6393-9. PubMed ID: 18826296
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Structure-activity relationships for 1',1'-dimethylalkyl-Delta8-tetrahydrocannabinols.
    Huffman JW; Miller JR; Liddle J; Yu S; Thomas BF; Wiley JL; Martin BR
    Bioorg Med Chem; 2003 Apr; 11(7):1397-410. PubMed ID: 12628666
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Enantioselective synthesis and pharmacology of 11-hydroxy-(1'S,2'R)-dimethylheptyl-delta 8-THC.
    Liddle J; Huffman JW; Wiley JL; Martin BR
    Bioorg Med Chem Lett; 1998 Aug; 8(16):2223-6. PubMed ID: 9873517
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Importance of the C-1 substituent in classical cannabinoids to CB2 receptor selectivity: synthesis and characterization of a series of O,2-propano-delta 8-tetrahydrocannabinol analogs.
    Reggio PH; Wang T; Brown AE; Fleming DN; Seltzman HH; Griffin G; Pertwee RG; Compton DR; Abood ME; Martin BR
    J Med Chem; 1997 Sep; 40(20):3312-8. PubMed ID: 9379452
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Synthesis and pharmacology of a very potent cannabinoid lacking a phenolic hydroxyl with high affinity for the CB2 receptor.
    Huffman JW; Yu S; Showalter V; Abood ME; Wiley JL; Compton DR; Martin BR; Bramblett RD; Reggio PH
    J Med Chem; 1996 Sep; 39(20):3875-7. PubMed ID: 8831752
    [No Abstract]   [Full Text] [Related]  

  • 11. Synthetic cannabinoids: the hidden side of Spice drugs.
    Pintori N; Loi B; Mereu M
    Behav Pharmacol; 2017 Sep; 28(6):409-419. PubMed ID: 28692429
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A novel probe for the cannabinoid receptor.
    Devane WA; Breuer A; Sheskin T; Järbe TU; Eisen MS; Mechoulam R
    J Med Chem; 1992 May; 35(11):2065-9. PubMed ID: 1317925
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Competitive inhibition of delta8-tetrahydrocannabinol and its active metabolites for cannabinoid receptor binding.
    Yamamoto I; Kimura T; Kamei A; Yoshida H; Watanabe K; Ho IK; Yoshimura H
    Biol Pharm Bull; 1998 Apr; 21(4):408-10. PubMed ID: 9586583
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Structure-activity analysis of anandamide analogs: relationship to a cannabinoid pharmacophore.
    Thomas BF; Adams IB; Mascarella SW; Martin BR; Razdan RK
    J Med Chem; 1996 Jan; 39(2):471-9. PubMed ID: 8558515
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Synthesis and pharmacological activity of a phosphate ester of delta8-tetrahydrocannabinol.
    Yoshimura H; Watanabe K; Oguri K; Fujiwara M; Ueki S
    J Med Chem; 1978 Oct; 21(10):1079-81. PubMed ID: 569207
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Some 11-substituted tetrahydrocannabinols. Synthesis and comparison with the potent cannabinoid metabolites 11-hydroxytetrahydrocannabinols.
    Wilson RS; Martin BR; Dewey WL
    J Med Chem; 1979 Jul; 22(7):879-82. PubMed ID: 448686
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hashish. Unsaturated side-chain analogues of delta8-tetrahydrocannabinol with potent biological activity.
    Razdan RK; Dalzell HC; Herlihy P; Howes JF
    J Med Chem; 1976 Nov; 19(11):1328-30. PubMed ID: 1003411
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Evaluation of agonist-antagonist properties of nitrogen mustard and cyano derivatives of delta 8-tetrahydrocannabinol.
    Wiley JL; Compton DR; Gordon PM; Siegel C; Singer M; Dutta A; Lichtman AH; Balster RL; Razdan RK; Martin BR
    Neuropharmacology; 1996; 35(12):1793-804. PubMed ID: 9076759
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Synthesis of 2-amido-2,3-dihydro-1H-phenalene derivatives as new conformationally restricted ligands for melatonin receptors.
    Mathé-Allainmat M; Gaudy F; Sicsic S; Dangy-Caye AL; Shen S; Brémont B; Benatalah Z; Langlois M; Renard P; Delagrange P
    J Med Chem; 1996 Aug; 39(16):3089-95. PubMed ID: 8759629
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pharmacophoric requirements for cannabinoid side chains: multiple bond and C1'-substituted delta 8-tetrahydrocannabinols.
    Papahatjis DP; Kourouli T; Abadji V; Goutopoulos A; Makriyannis A
    J Med Chem; 1998 Mar; 41(7):1195-200. PubMed ID: 9544219
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.